Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Xenetic Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Xenetic Biosciences Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Xenetic Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Xenetic Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Xenetic Biosciences Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Xenetic Biosciences Inc, Pharmaceuticals & Healthcare, Deal Details 11
Asset Purchase 11
Xenetic Biosciences Acquires Rights to Virexxa from Kevelt 11
Partnerships 12
Xenetic Biosciences Enters into Agreement with Excivion 12
Licensing Agreements 13
Baxalta Enters into Licensing Agreement with Xenetic Biosciences 13
Equity Offering 14
Xenetic Biosciences Plans to Raise up to USD50 Million in Public Offering of Securities 14
Xenetic Biosciences Raises USD10 Million in Public Offering of Units 15
Xenetic Biosciences Raises USD10 Million in Private Placement of Shares 16
Xenetic Biosciences Raises USD0.3 Million in Private Placement of Shares 17
Debt Offering 18
Xenetic Biosciences Raises USD3 Million in Private Placement of 10% Notes 18
Acquisition 19
OPKO Health Acquires 6.3% Interest in Xenetic Biosciences 19
General Sales Completes Reverse Acquisition Transaction with Xenetic Biosciences 20
Xenetic Biosciences Completes Acquisition Of SymbioTec For US$14.4 Million 21
Xenetic Biosciences Inc – Key Competitors 22
Xenetic Biosciences Inc – Key Employees 23
Xenetic Biosciences Inc – Locations And Subsidiaries 24
Head Office 24
Other Locations & Subsidiaries 24
Recent Developments 25
Financial Announcements 25
Nov 15, 2017: Xenetic Biosciences Reports 2017 Third Quarter Financial Results and Provides Corporate Update 25
Aug 15, 2017: Xenetic Biosciences Reports 2017 Second Quarter Financial Results and Provides Business Update 27
May 16, 2017: Xenetic Biosciences Reports 2017 First Quarter Financial Results and Provides Business Update 29
Apr 03, 2017: Xenetic Biosciences Reports 2016 Year End Financial Results and Provides Business Update 30
Corporate Communications 32
Oct 31, 2017: Xenetic Biosciences Appoints Jeffrey F. Eisenberg as Chief Executive Officer 32
Aug 14, 2017: Xenetic Biosciences Announces Appointment of Three Directors to the Board 33
Apr 04, 2017: Xenetic Biosciences Expands Executive Management Team with Appointment of James F. Parslow, MBA, CPA as Chief Financial Officer 34
Jan 04, 2017: Xenetic Biosciences Appoints Curtis A. Lockshin, Ph.D. as Chief Scientific Officer 35
Product News 36
Apr 20, 2017: Xenetic Biosciences’ PolyXen Platform Technology Accepted for Poster Presentation at the 13th Annual Protein Engineering Summit (PEGS) Boston 36
Other Significant Developments 37
Mar 27, 2017: Xenetic Biosciences Provides Update on Patent Portfolio Development 37
Appendix 38
Methodology 38
About GlobalData 38
Contact Us 38
Disclaimer 38
Xenetic Biosciences Inc, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Xenetic Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Xenetic Biosciences Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Xenetic Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Xenetic Biosciences Inc, Deals By Therapy Area, 2012 to YTD 2018 9
Xenetic Biosciences Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Xenetic Biosciences Acquires Rights to Virexxa from Kevelt 11
Xenetic Biosciences Enters into Agreement with Excivion 12
Baxalta Enters into Licensing Agreement with Xenetic Biosciences 13
Xenetic Biosciences Plans to Raise up to USD50 Million in Public Offering of Securities 14
Xenetic Biosciences Raises USD10 Million in Public Offering of Units 15
Xenetic Biosciences Raises USD10 Million in Private Placement of Shares 16
Xenetic Biosciences Raises USD0.3 Million in Private Placement of Shares 17
Xenetic Biosciences Raises USD3 Million in Private Placement of 10% Notes 18
OPKO Health Acquires 6.3% Interest in Xenetic Biosciences 19
General Sales Completes Reverse Acquisition Transaction with Xenetic Biosciences 20
Xenetic Biosciences Completes Acquisition Of SymbioTec For US$14.4 Million 21
Xenetic Biosciences Inc, Key Competitors 22
Xenetic Biosciences Inc, Key Employees 23
Xenetic Biosciences Inc, Subsidiaries 24
List of Figures
Xenetic Biosciences Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Xenetic Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Xenetic Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Xenetic Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Xenetic Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Xenetic Biosciences Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7
Xenetic Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Xenetic Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9